Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH is an Fmoc-protected dipeptide acid featuring a leucine residue linked to a threonine side chain bearing a psi(Me,Me)pro substituent, where the threonine hydroxyl is incorporated into a constrained, peptidomimetic-like framework. The molecule contains an N-terminal Fmoc carbamate for orthogonal protection during solid-phase peptide synthesis, a free C-terminal carboxylic acid for coupling, and a stereodefined peptide backbone that preserves chiral information at the leucine and threonine centers. The psi(Me,Me)pro side-chain architecture introduces gem-dimethyl character and a conformationally biased functional motif that can modulate amide bond geometry and local sterics in downstream peptide analogs. The presence of protected and reactive functional groups makes the compound suitable for controlled peptide assembly, side-chain patterning, and subsequent derivatization into unnatural amino acid-containing scaffolds.

1. Peptide Synthesis

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH supports peptide building workflows where N-Fmoc protection enables stepwise coupling and deprotection strategies compatible with standard peptide synthesis cycles. The C-terminal carboxylic acid participates in amide bond formation, while the leucine residue provides a hydrophobic side-chain handle that can influence solubility and conformational preferences in longer sequences. The threonine psi(Me,Me)pro side-chain substituent functions as a constrained stereochemical element, allowing incorporation of a peptidomimetic-like motif into peptide chains without relying on a free hydroxyl for every synthetic step. Downstream, the resulting peptide products can be used to generate libraries of constrained analogs for sequence-dependent studies and for constructing unnatural amino acid-containing peptide frameworks.

2. Peptidomimetics And SAR Studies

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH is suitable for peptidomimetic construction in structure-activity relationship studies where conformational bias and side-chain sterics are key variables. The leucine and threonine-derived backbone segments provide defined amide connectivity, while the psi(Me,Me)pro group introduces gem-dimethyl substitution that can alter hydrogen-bonding patterns and local rotational freedom around the side chain. The stereochemical integrity of the protected peptide fragment helps maintain consistent three-dimensional presentation when incorporated into larger analogs. The compound can be employed as a defined chiral fragment for generating SAR panels that probe how constrained threonine-like motifs affect binding-site complementarity and peptide-like stability.

3. Chemical Biology Probes

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH can be applied in chemical biology research to produce peptide probes that require controlled N-terminal protection and a functional side-chain scaffold for conjugation-ready architectures. The Fmoc-protected N-terminus enables assembly of labeled or affinity-tagged sequences without exposing reactive amines prematurely, supporting modular probe synthesis. The C-terminal carboxylic acid allows attachment into larger constructs, including sequences designed for cell-permeability tuning or for incorporation into probe scaffolds that mimic threonine-containing motifs. The constrained psi(Me,Me)pro side-chain can reduce conformational heterogeneity, which may improve reproducibility of probe behavior in biochemical assays that depend on defined peptide geometry.

4. Protein Engineering Fragments

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH is applicable to protein engineering and peptide-to-protein mapping workflows where defined peptide fragments are used to interrogate interaction surfaces. The dipeptide acid format supports incorporation into longer engineered sequences, and the N-Fmoc protection strategy aligns with orthogonal assembly approaches used to generate peptide segments for subsequent ligation or functionalization. The leucine hydrophobic side chain and the stereodefined threonine psi(Me,Me)pro motif can serve as local structural determinants that influence helix propensity, turn formation, or binding interface shape in engineered constructs. Downstream use can include preparing constrained peptide segments for studying recognition events, validating motif hypotheses, or generating substrates and inhibitors that reflect specific stereochemical features.

5. Pharmaceutical Intermediate Preparation

Fmoc-Leu-Thr(Psi(Me,Me)pro)-OH functions as a chiral, protected peptide intermediate for fine chemical synthesis routes that require controlled stereochemistry and reliable peptide coupling compatibility. The N-terminal Fmoc carbamate provides a stable protecting-group handle during manufacturing-scale assembly, while the free C-terminal carboxylic acid supports conversion into activated coupling partners or direct incorporation into protected peptide sequences. The psi(Me,Me)pro side-chain introduces a defined, gem-dimethyl constrained motif that can be carried through synthetic sequences to deliver peptidomimetic drug-like fragments. The resulting intermediates can be used in downstream synthesis of larger constrained peptides, enabling consistent generation of amino acid derivative-containing scaffolds relevant to industrial peptide chemistry and applied process development.

1. Cationic cell-penetrating peptides are potent furin inhibitors

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. Olfactory receptor based piezoelectric biosensors for detection of alcohols related to food safety applications

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. High fat diet and GLP-1 drugs induce pancreatic injury in mice